SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,067.81 685.34
( 0.95%)

Global Indices

Nasdaq

51,284.68 86.72
(0.17%)

Dow Jones

7,793.50 49.78
(0.64%)

Hang Seng

70,716.70 769.84
(1.10%)

Nikkei 225

10,489.44 27.49
(0.26%)

Forex

USD-INR

95.96 -0.21
(-0.22%)

EUR-INR

107.98 -0.51
(-0.47%)

GBP-INR

127.02 -0.14
(-0.11%)

JPY-INR

0.61 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

515.9184612

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

20.7

2341.56

EPS(TTM)

Face Value()

Div & Yield %

84.64

0.57

Back

Trent consolidated net profit rises 20.79% in the June 2026 quarter

Aug 06,2026

Net profit of Trent rose 20.79% to Rs 519.01 crore in the quarter ended June 2026 as against Rs 429.69 crore during the previous quarter ended June 2025. Sales rose 17.84% to Rs 5754.71 crore in the quarter ended June 2026 as against Rs 4883.48 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5754.71	4883.48	18
OPM %	19.45	17.36	-
PBDT	1102.00	857.62	28
PBT	691.84	564.69	23
NP	519.01	429.69	21

73,067.81 685.34 ( 0.95%)

51,284.68 86.72 (0.17%)

7,793.50 49.78 (0.64%)

70,716.70 769.84 (1.10%)

10,489.44 27.49 (0.26%)

95.96 -0.21 (-0.22%)

107.98 -0.51 (-0.47%)

127.02 -0.14 (-0.11%)

0.61 0.00 (-0.10%)